Dietary preference for fat may increase risk for obesity. It is a complex behavior regulated in part by the amygdala, a brain structure involved in reward processing and food behavior, and modulated by genetic factors. Here, we conducted a genome-wide association study (GWAS) to search for gene loci associated with dietary intake of fat, and we tested whether these loci are also associated with adiposity and amygdala volume. We studied 598 adolescents (12-18 years) recruited from the French-Canadian founder population and genotyped them with 530 011 single-nucleotide polymorphisms. Fat intake was assessed with a 24-hour food recall. Adiposity was examined with anthropometry and bioimpedance. Amygdala volume was measured by magnetic resonance imaging. GWAS identified a locus of fat intake in the m-opioid receptor gene (OPRM1, rs2281617, P ¼ 5.2 Â 10 À 6 ), which encodes a receptor expressed in the brain-reward system and shown previously to modulate fat preference in animals. The minor OPRM1 allele appeared to have a 'protective' effect: it was associated with lower fat intake (by 4%) and lower body-fat mass (by B2 kg, P ¼ 0.02). Consistent with the possible amygdala-mediated inhibition of fat preference, this allele was additionally associated with higher amygdala volume (by 69 mm 3 , P ¼ 0.02) and, in the carriers of this allele, amygdala volume correlated inversely with fat intake (P ¼ 0.02). Finally, OPRM1 was associated with fat intake in an independent sample of 490 young adults. In summary, OPRM1 may modulate dietary intake of fat and hence risk for obesity, and this effect may be modulated by subtle variations in the amygdala volume.
INTRODUCTION
Research in humans and experimental animals suggests that excessive intake of fat contributes to obesity. [1] [2] [3] [4] [5] [6] [7] [8] [9] Fats compared with other macronutrients, namely carbohydrates and proteins, are of higher energy density and higher energy efficiency. Each gram of fats contains double the energy of each gram of carbohydrates or proteins 10 and, even when the same energy is consumed, almost all calories eaten as fats are stored, whereas 5-10% and 20-30% of calories eaten as carbohydrates and proteins, respectively, are lost during their absorption, processing and storage. 11 Preference for certain foods, including fats, is a complex behavior regulated by: (a) homeostatic mechanisms, which serve to maintain energy balance, and (b) reward-related mechanisms, which process the hedonic properties of food independently of energy status. 12 The latter mechanisms may overlap with those processing the hedonic properties of drugs of abuse 13 and involve brain structures involved in processing reward. [14] [15] [16] [17] [18] Amygdala is a brain-reward structure involved potentially in both the development of drug addiction and the regulation of fat preference. Regarding the former, lower amygdala volume is seen in individuals with alcohol addiction 14, 15 and in their adolescent and young-adult offspring, suggesting that lower amygdala volume may be a risk factor for addiction rather than its consequence. 16 Regarding the role of amygdala in the regulation of fat preference, it has been shown that the amygdala is activated by high-fat vs low-fat stimuli in human functional magnetic resonance imaging studies. 19 The net outcome of this activation may be a decrease of fat intake, as amygdala volume correlates inversely with fat intake in humans 20 and its activation by intra-amygdalar administration of neuropeptide Y 17 or enterostatin 18 decreases preference for fat in experimental animals. Taken together, the above research indicates that reduced size and/or lesser activation of the amygdala may increase risk for addiction and dietary preference for fat.
Genes have a significant role in determining inter-individual differences in fat preference/intake, as suggested by animal and human studies. [21] [22] [23] [24] [25] [26] Very little is known, however, about individual genes (and hence mechanistic pathways) involved. Therefore, we performed a genome-wide association study (GWAS) to search for such genes. In addition, we tested whether gene loci identified in this GWAS are also associated with differences in adiposity and the size of the amygdala. We performed these studies in a population-based sample of 598 adolescents who were recruited from the French-Canadian population with known genetic founder effects. [27] [28] [29] The power of genetic analyses is expected to be higher in founder than regular outbred populations due to more homogenous genetic and environmental backgrounds and, in turn, fewer genes contributing to complex traits, such as fat intake studied here. 30 In addition, we tested our primary findings in an independent sample of 490 young adults of European ancestry.
MATERIALS AND METHODS

The Saguenay Youth Study (SYS)
The SYS included 598 Caucasian adolescents, aged 12-18 years, who were recruited from the genetic founder population [27] [28] [29] of French-Canadians living in the Saguenay-Lac St Jean region of Quebec, Canada, as part of the SYS. 31 The prevalence of several recessive disorders is higher in the Saguenay-Lac St Jean region than in other populations, 27 and limited allelic diversity exists among patients with these disorders. 28, 29 The SYS is an ongoing, population-based cross-sectional study of cardiovascular, metabolic and mental health in adolescence. 31 It is a family-based study focused on collecting sib-pairs. Recruitment and selection criteria have been described previously. 31 Written consent of the parents and assent of the adolescents were obtained. The Research Ethics Committee of the Chicoutimi Hospital approved the study. Descriptive characteristics of the studied participants are provided in Supplementary Table 1 .
Dietary intake of fat was assessed with a 24-hour food recall, which is a well-established method of assessing diet used, for example, in the U.S. National Health and Nutrition Examination Survey, the only nationally representative dietary survey in the United States. 32, 33 Using this method, information on the foods and drinks consumed during the past 24 h is collected in a structured interview conducted by a trained nutritionist and then analyzed with the Recipe File (USDA) to derive energy and macronutrient (that is, carbohydrate, fat and protein) intake. This instrument has been validated for Quebec youth. 34 Magnetic resonance imaging of the amygdala. Magnetic resonance T1-weighted images (1-mm isotropic) of the brain were acquired on a Phillips 1.0-T superconducting magnet (Gyroscan NT, Philips Healthcare, Best, The Netherlands). The details of magnetic resonance imaging data collection were reported previously. 31 Volumes of the whole brain and of the right and left amygdala were obtained with FreeSurfer (FreeSurfer Version 5.0.0). 35 Briefly, FreeSurfer is a collection of image-analysis algorithms that assigns automatically anatomical labels to each voxel of the magnetic resonance volume; this is achieved by combining probabilistic information about the global location of a structure in the atlas space with local spatial relationships between adjacent structures. 36 In this manner, we obtained volumes of the left and right amygdala. In the analyses reported here, we used total (left þ right) volume of the amygdala.
Adiposity. Weight (0.1-kg precision) and height (1-mm precision) were measured and body mass index (BMI) was calculated as body weight in kg divided by height in m squared. Total body fat was assessed by multifrequency bioimpedance analysis (Xitron Technologies, San Diego, CA, USA). Adolescents were asked to refrain from caffeine, alcohol and vigorous activity 24 h before the measurement. The measurement was made after a 20-min stabilization period during which the participants were resting in a supine position.
Genotypes. All adolescents (n ¼ 602) were genotyped with the Illumina Human610-Quad BeadChip (Illumina, San Diego, CA, USA) that includes 582 539 single-nucleotide polymorphisms (SNPs) distributed across 22 autosomal chromosomes. The genotyping was conducted at the Center National de Gé notypage (Paris, France) where genotype calling was made for 567 726 SNPs. We excluded SNPs with call rate o95% and minor allele frequency o0.01, and SNPs that were not in Hardy-Weinberg equilibrium (Po1 Â 10 À 4 ); a total of 530 011 SNPs passed these quality-control criteria and were included in GWAS. On average, the call rate of these SNPs was 99.2%. In addition, three participants were removed based on principal component analysis of population structure performed with HapMap II (release 22) and SYS genotypes, 37 and one participant was excluded due to 43% of missing genotypes; the final number of adolescents studied here was 598.
Statistical methods. GWAS of fat preference was conducted using Merlin-1.1.2, under an additive model. 38, 39 With Merlin, a simple regression model is fitted to the trait under study and a variance component approach is used to account for correlation between observed phenotypes within each family (that is, to adjust for family relatedness of siblings in the SYS). For individuals with missing genotypes, the Lander-Green algorithm is employed to estimate an expected genotype score. 40 In the SYS sample, fat preference was normally distributed and no statistical outliers (mean ± 3 s.d.'s) were present. Age and sex were included as potential confounders.
Secondary analyses were aimed at examining whether the most significant GWAS-identified locus of fat intake (rs2281617) is also associated with energy, carbohydrate and protein intakes and with adiposity and amygdala volume; these analyses were performed with multivariate linear model, while adjusting for age and sex (and height when relevant). For each outcome, a preliminary analysis involved assessing the normality assumption, on which the statistical inference about the linear-model estimates relies. Body-fat mass and BMI had positively skewed distributions and were log transformed, using logarithm with base 10, which improved the fit. In addition, statistical outliers (that is, values outside mean ± 3 s.d.'s) were excluded in the cases of energy, carbohydrates and protein intakes, body-fat mass, BMI and amygdala OPRM1 and fat intake A Haghighi et al volume (no8). The number of minor allele T homozygotes at rs2281617 was o10; therefore, TT-homozygotes were pooled together with TC-heterozygotes as T-carriers.
The Toronto Nutrigenomics and Health Study (TNHS)
The TNHS is a cross-sectional study of diet, genotype and biomarkers of chronic disease in a population of young adults recruited from the University of Toronto, Toronto, Canada. Recruitment criteria are described elsewhere. 41 A subset of the TNHS including 490 Caucasian adults (20-29 years old) whose food intake was assessed by a 1-month, 196-item, semiquantitative food-frequency questionnaire 41 and who were genotyped with the Affymetrix SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA) was studied here. In these individuals, body weight and height were measured in a laboratory setting. 41 Descriptive characteristics of the studied participants are provided in Supplementary Table 1. SNPs that passed quality control and were located within the m-opioid receptor gene (OPRM1) were tested for association. Figure 2 . Association of the OPRM1 locus (rs2281617) with fat, carbohydrate, protein and energy intakes, adiposity measures and amygdala volume in the Saguenay Youth Study. Means ± s.e.'s, adjusted for age, sex and, when appropriate, height, are shown. 
RESULTS
GWAS of fat intake in the SYS
The most significant gene-associated locus of fat intake was found in the m-opioid receptor gene (OPRM1, rs2281617, P ¼ 5.2 Â 10 À 6 , Table 1 and Figure 1) . At this locus, T-carriers compared with CChomozygotes showed lower intake of fat (by 4%, Figure 2 ) and higher intake of carbohydrates (by 3%, P ¼ 0.002) and no differences in intake of protein (P ¼ 0.55) and energy (P ¼ 0.69, Figure 2 ).
OPRM1 locus and adiposity in the SYS At the OPRM1 locus, T-carriers (vs CC-homozygotes) who showed lower fat intake also demonstrated lower body weight (by B3 kg, P ¼ 0.02), BMI (by B1 kg m À 2 , P ¼ 0.01) and body-fat mass (by B2 kg, P ¼ 0.02; Figure 2 ).
OPRM1 locus and amygdala volume in the SYS Previous human and animal research suggests an inverse relationship between the size/activation of the amygdala and fat preference/intake. 17, 18, 20 Consistent with this research, the OPRM1 T-carriers who showed lower fat intake when compared with CChomozygotes demonstrated higher amygdala volume (by 69 mm 3 , P ¼ 0.02, Figure 2 ). In addition, only in these T-carriers, amygdala volume correlated inversely with fat intake (T-carriers: r ¼ À 0.13, P ¼ 0.02; CC-homozygotes: r ¼ À 0.01, P ¼ 0.66), and this relationship remained virtually unchanged after additional adjusting for the overall brain volume (T-carriers: r ¼ À 0.13, P ¼ 0.04; CChomozygotes: r ¼ À 0.01, P ¼ 0.34).
OPRM1 locus, fat intake and adiposity in the TNHS Next, we tested whether OPRM1 is also associated with fat intake in an independent sample of young adults (n ¼ 490). We found that the SNP most significantly associated with fat intake (rs518596, P ¼ 0.009) in this sample was located in the same intron as the SNP most significantly associated with fat intake in the SYS (rs2281617, Supplementary Figure 1) . Similar to the SYS, the allele associated with lower fat intake was also associated with lower BMI (P ¼ 0.005).
Although the SNPs associated with fat intake in the SYS (rs2281617) and TNHS (rs518596) were located in the same last intron of OPRM1, they did not replicate each other (Table 2 ). They were not in linkage disequilibrium (D 0 o0.48). In fact, they were located on opposite sites of a recombination hot spot at which recombination rate was about 60 times higher than that across the genome 42 ( Supplementary Figure 1) . This high recombination rate is likely to prevent direct replication, 43 but it does not exclude the possibility that, in each sample, the identified SNP is in linkage disequilibrium with and detects a signal of the same causal variant. Further studies are required to confirm this possibility.
DISCUSSION
The results of the present study suggest that OPRM1 may modulate dietary intake of fat and hence the risk for obesity, and that this effect may be associated with subtle variations in the amygdala volume.
OPRM1 encodes the m-opioid receptor, which shows high affinity for endogenous (b-endorphin and enkephalin) and exogenous (morphine, heroin and methadone) opioids. The gene is highly expressed in the brain areas processing reward associated not only with drugs of abuse but also with palatable foods and, in particular, dietary fat. 44, 45 The results of the present study demonstrating that OPRM1 is associated with fat intake are consistent with previous research in experimental animals showing that administration of m-opioid receptor agonists increases intake of fat. [46] [47] [48] [49] In the present study, the minor T allele appeared to have a 'protective' effect: it was associated with lower fat intake and lower body adiposity. We speculate that the minor T allele detects a signal-in OPRM1-of a loss-of-function in this gene. This allele was additionally associated with higher carbohydrate intake and no differences in energy intake ( Figure 2) . These results are also consistent with previous research in experimental animals showing that while the administration of m-opioid receptor agonists increases intake of fat, it either decreases or shows no impact on the intake of carbohydrates, and that these effects are seen independently of energy status (that is, in both satiated and hungry animals). 46 In the present study, the OPRM1 SNP most significantly associated with fat intake was rs2281617. The same SNP has previously been associated with self-reported euphoria in response to amphetamine in a community-based sample. 50 Importantly, T-carriers (vs CC-homozygotes) who showed lower fat intake in our study demonstrated lower amphetamine-induced euphoria in that study. 50 Taken together, these data support the possibility of a mechanistic overlap between processing reward from drugs of abuse and fatty foods.
In the current study, T-carriers vs CC-homozygotes demonstrated not only lower fat intake but also higher amygdala volume and, in T-carriers, amygdala volume correlated inversely with fat intake. The amygdala is a structure of the brain-reward system studied extensively in the context of both drug addiction and the regulation of fat preference. [14] [15] [16] Inverse relationships between amygdala volume and both fat intake 20 and alcohol craving 15 have been reported previously. It has also been shown that activation of the amygdala by intra-amygdalar administration of neuropeptide Y 17 or enterostatin 18 decreases preference for fat in experimental animals. The mechanisms through which the m-opioid receptor may influence amygdala volume are not clear at present. It has been reported that the m-opioid receptor is functionally present on pre-synaptic glutamatergic terminals in the amygdala and that its activation decreases the release of glutamate, 51 a major excitatory neurotransmitter. Considering these relationships and the fact that enhanced excitatory neurotransmission and associated metabolic demands may induce cellular adaptations, such as increased vascularization and augmented number of glia, and that these adaptations may translate into an increase in the volume of a given brain structure, a loss-of-function mutation of OPRM1 would be expected to increase this excitatory neurotransmission and hence volume of the amygdala (Figure 3, left pathway) . Alternatively, OPRM1 may influence embryonic development of the amygdala and, subsequently, its function. It has been shown that Oprm1 is expressed very early on in the embryonic rat brain, including the amygdaloid complex, 52 and that opioids may inhibit neurogenesis 53 ( Figure 3 , right pathway).
In this study, the more frequent OPRM1 allele was associated with higher fat preference and adiposity. From an evolutionary perspective, this pattern is consistent with the thrifty genotype OPRM1 and fat intake A Haghighi et al hypothesis 54 according to which limited food resources available to our ancestors thousands years ago favored selection of alleles enhancing energy supply and thus survival and reproductive fitness. In today's conditions of plentiful nutrition, however, these alleles predispose to obesity and related disorders. 55 In summary, the results of the present study suggest that OPRM1 may be involved in the regulation of dietary preference for fat and, perhaps through this pathway, in the development of obesity. The results also suggest that this effect of OPRM1 may be mediated, at least in part, through its influences on amygdala volume. OPRM1 and fat intake A Haghighi et al
